Riskpilot← Back to searchSign inGet full accessJJ PHACO II AS
ASActiveOrg 917400660Bergesvevegen 124A, 2618 LillehammerMedical specialists activities · NACE 8622Est. 20162 employees
Revenue 2020
NOK 8M
-6% vs 2019
EBITDA margin
32.3%
-20% vs 2019
Equity ratio
77.6%
Financial strength
Net profit 2020
NOK 1,6M
-24% vs 2019
| Revenue | NOK 8M | -6% |
| EBITDA | NOK 2,6M | -20% |
| Net profit | NOK 1,6M | -24% |
| Total assets | NOK 5,4M | +14% |
| Equity | NOK 4,2M | +60% |
| Employees | 2 | — |
Legal name
JJ PHACO II AS
Org number
917400660
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
29. juni 2016
Share capital
NOK 10 000 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Medisinsk praksis som øyespesialist, samt andre produkter/tjenester som naturlig hører til dette. Herunder å delta i andre selskaper med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak. Selskapet kan også drive med kjøp/drift av fast eiendom.
Address
Bergesvevegen 124A, 2618 Lillehammer
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3 991 | 8 278 | 7 923 | 8 538 | 7 999 |
| Staff expenses | −784 | −2 151 | −2 126 | −2 200 | −2 187 |
| EBITDA | 1 565 | 2 772 | 2 890 | 3 225 | 2 580 |
| Depreciation & amort. | −156 | −350 | −509 | −535 | −548 |
| EBIT | 1 409 | 2 422 | 2 381 | 2 690 | 2 032 |
| Net financials | −21 | −45 | −36 | −13 | 0 |
| Profit before tax | 1 388 | 2 376 | 2 346 | 2 677 | 2 032 |
| Tax | 341 | 567 | 538 | 589 | 447 |
| Net profit | 1 047 | 1 809 | 1 808 | 2 088 | 1 585 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 3 465 | 5 180 | 5 306 | 4 794 | 5 443 |
| Equity | 533 | 1 343 | 2 151 | 2 639 | 4 224 |
| Long-term debt | 1 435 | 1 155 | 820 | 0 | 0 |
| Short-term debt | 1 497 | 2 683 | 2 335 | 2 156 | 1 219 |
| Total debt | 2 932 | 3 838 | 3 155 | 2 156 | 1 219 |
EBITDA margin
32.3%
This company
15.8%
Market median
+104% vs market
20162020
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20162020
Return on equity
37.5%
This company
18.4%
Market median
+104% vs market
20162020
Net profit margin
19.8%
This company
8.1%
Market median
+144% vs market
20162020
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20162020
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-06-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IJ Deputy Member | Deputy Member | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JJ PHACO II AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Johanne Løkkevik | Deputy Member | 0 companies |
| Jacob Lindbom Jacobsen | Chairman | 0 companies |